Quest Diagnostics PE Ratio 2010-2024 | DGX

Current and historical p/e ratio for Quest Diagnostics (DGX) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Quest Diagnostics PE ratio as of November 07, 2024 is 17.55.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Quest Diagnostics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-06 155.18 20.86
2024-09-30 154.48 $7.44 20.76
2024-06-30 135.47 $7.41 18.28
2024-03-31 130.99 $7.43 17.63
2023-12-31 134.97 $7.49 18.02
2023-09-30 118.60 $6.66 17.81
2023-06-30 136.11 $6.87 19.81
2023-03-31 136.32 $6.78 20.11
2022-12-31 150.06 $7.92 18.95
2022-09-30 117.07 $10.17 11.51
2022-06-30 126.27 $12.02 10.50
2022-03-31 129.32 $15.02 8.61
2021-12-31 162.75 $15.56 10.46
2021-09-30 136.09 $16.65 8.17
2021-06-30 123.03 $16.77 7.34
2021-03-31 119.07 $13.17 9.04
2020-12-31 110.07 $10.44 10.54
2020-09-30 105.24 $8.09 13.01
2020-06-30 104.25 $5.51 18.92
2020-03-31 72.94 $5.81 12.55
2019-12-31 96.52 $6.28 15.37
2019-09-30 96.25 $5.34 18.02
2019-06-30 91.08 $5.31 17.15
2019-03-31 79.98 $5.22 15.32
2018-12-31 73.60 $5.29 13.91
2018-09-30 94.92 $6.19 15.33
2018-06-30 96.27 $5.81 16.57
2018-03-31 87.38 $5.61 15.58
2017-12-31 85.42 $5.50 15.53
2017-09-30 80.83 $4.77 16.94
2017-06-30 95.55 $4.96 19.27
2017-03-31 84.02 $4.96 16.94
2016-12-31 78.25 $4.50 17.39
2016-09-30 72.06 $4.70 15.33
2016-06-30 68.66 $5.71 12.02
2016-03-31 59.93 $5.15 11.64
2015-12-31 59.33 $4.87 12.18
2015-09-30 50.96 $4.87 10.46
2015-06-30 59.80 $3.40 17.59
2015-03-31 63.05 $3.51 17.96
2014-12-31 54.76 $3.80 14.41
2014-09-30 49.28 $3.48 14.16
2014-06-30 47.40 $5.28 8.98
2014-03-31 46.52 $5.43 8.57
2013-12-31 42.76 $5.57 7.68
2013-09-30 49.35 $4.94 9.99
2013-06-30 48.19 $3.27 14.74
2013-03-31 44.65 $3.31 13.49
2012-12-31 45.61 $3.45 13.22
2012-09-30 49.65 $4.30 11.55
2012-06-30 46.76 $4.36 10.72
2012-03-31 47.60 $4.27 11.15
2011-12-31 44.94 $4.14 10.85
2011-09-30 38.12 $3.91 9.75
2011-06-30 45.64 $3.97 11.50
2011-03-31 44.42 $4.02 11.05
2010-12-31 41.46 $4.05 10.24
2010-09-30 38.77 $4.06 9.55
2010-06-30 38.08 $3.95 9.64
2010-03-31 44.53 $3.89 11.45
2009-12-31 46.05 $3.88 11.87
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.320B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.921B 12.66
DaVita (DVA) United States $12.060B 15.60
Encompass Health (EHC) United States $10.267B 24.21
Chemed (CHE) United States $8.277B 25.44
Elanco Animal Health (ELAN) United States $6.357B 14.29
RadNet (RDNT) United States $5.166B 122.54
Option Care Health (OPCH) United States $3.999B 18.95
Amedisys (AMED) United States $3.199B 22.78
Astrana Health (ASTH) United States $2.920B 41.31
LifeStance Health (LFST) United States $2.728B 0.00
Addus HomeCare (ADUS) United States $2.375B 27.86
U.S Physical Therapy (USPH) United States $1.464B 38.53
Pennant (PNTG) United States $1.004B 46.00
Aveanna Healthcare Holdings (AVAH) United States $0.929B 0.00
Atai Life Sciences (ATAI) Germany $0.198B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.013B 0.00
Ontrak (OTRK) United States $0.007B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00